Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 122

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 122
---
 and establish additional collaborations for its product candidates or future product candidates; |

| ● | the continued service of the Company’s key scientific or management personnel; |

| ● | the Company’s ability to establish commercialization and marketing capabilities for any future approved products; |

| ● | regulatory developments in the United States and foreign countries; |

68

| ● | the Company’s ability to obtain and maintain coverage and adequate reimbursement from third-party payers and governments for any other future approved indications or products; |

| ● | the Company’s planned use of its cash and cash equivalents and the clinical milestones it expects to fund with such proceeds; |

| ● | the accuracy of its estimates regarding expenses, future revenues and capital requirements; |

| ● | the Company’s ability to obtain funding for its operations; |

| ● | the Company’s ability to obtain and maintain intellectual property protection for its product candidates or future product candidates and the Company’s ability to operate its business without infringing on the intellectual property rights of others; |

| ● | the Company’s ability to maintain proper and effective internal controls over financial reporting and to remediate and prevent material weaknesses in the Company’s internal controls; |

| ● | the success of competing drugs that are or may become available; and |

| ● | the potential effects of any global health crises, geopolitical tensions and macroeconomic conditions on its business, operations, and clinical development and regulatory timelines and plans. |

You should refer to the “ Risk Factors” section herein for a discussion of material factors that may cause the Company’s actual results to differ materially from those expressed or implied by its forward-looking statements. As a result of these factors, the Company cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if the Company’s forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by the Company or any other person that the Company will achieve its objectives and plans in any specified time frame or at all. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You should read this prospectus and the documents that the Company references in this prospectus and have filed as exhibits to this prospectus completely and with the understanding that the Company’s actual future results may be materially different from what it expects. The Company qualifies all of its forward-looking statements by